Skip to main content

Advertisement

Log in

Perioperative Inpatient Opioid Consumption Following Autologous Free-Flap Breast Reconstruction Patients: An Examination of Risk and Patient-Reported Outcomes

  • Reconstructive Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The response to the unprecedented opioid crisis in the US has increased focus on multimodal pain regimens and enhanced recovery after surgery (ERAS) pathways to reduce opioid use. This study aimed to define patient and system-level factors related to perioperative consumption of opioids in autologous free-flap breast reconstruction.

Methods

We conducted a retrospective study to identify patients who underwent autologous breast reconstruction between 2010 and 2016. A multivariate linear regression model was developed to assess patient and system-level factors influencing opioid consumption. Opioid consumption was then dichotomized as total postoperative opioid consumption above (high) and below (low) the 50th percentile to afford more in-depth interpretation of the regression analysis. Secondary outcome analyses examined postoperative complications and health-related quality-of-life outcomes using the BREAST-Q.

Results

Overall, 601 patients were included in the analysis. Unilateral reconstruction, lower body mass index, older age, and administration of ketorolac and liposomal bupivacaine were associated with lower postoperative opioid consumption. In contrast, history of psychiatric diagnoses was associated with higher postoperative opioid consumption. There was no difference in the rates of postoperative complications when comparing the groups, although patients who had lower postoperative opioid consumption had higher BREAST-Q physical well-being scores.

Conclusion

System-level components of ERAS pathways may reduce opioid use following autologous breast reconstruction, but surgical and patient factors may increase opioid requirements in certain patients. ERAS programs including liposomal bupivacaine and ketorolac should be established on a system level in conjunction with continued focus on individualized care, particularly for patients at risk for high opioid consumption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Wallace MS, Wallace AM, Lee J, Dobke MK. Pain after breast surgery: a survey of 282 women. Pain. 1996;66:195–205.

    Article  CAS  PubMed  Google Scholar 

  2. Nelson JA, Fischer JP, Pasick C, et al. Chronic pain following abdominal free flap breast reconstruction: a prospective pilot analysis. Ann Plast Surg. 2013;71:278–82.

    Article  CAS  PubMed  Google Scholar 

  3. Roth RS, Lowery JC, Davis J, Wilkins EG. Persistent pain following postmastectomy breast reconstruction: long-term effects of type and timing of surgery. Ann Plast Surg. 2007;58:371–6.

    Article  CAS  PubMed  Google Scholar 

  4. Kulkarni AR, Pusic AL, Hamill JB, et al. Factors associated with acute postoperative pain following breast reconstruction. JPRAS Open. 2017;11:1–13.

    Article  PubMed  Google Scholar 

  5. Vadivelu N, Schreck M, Lopez J, Kodumudi G, Narayan D. Pain after mastectomy and breast reconstruction. Am Surg. 2008;74:285–96.

    Article  PubMed  Google Scholar 

  6. Gartner R, Jensen MB, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009;302:1985–92.

    Article  PubMed  Google Scholar 

  7. Khan JS, Ladha KS, Abdallah, Clark H. Treating Persistent Pain After Breast Cancer Surgery. Drugs 2020: 80;23–31.

  8. Gartner R, Kroman N, Callesen T, Kehlet H. Multimodal prevention of pain, nausea and vomiting after breast cancer surgery. Minerva Anestesiol. 2010;76:805–13.

    CAS  PubMed  Google Scholar 

  9. Lee JS, Hu HM, Edelman AL, et al. New persistent opioid use among patients with cancer after curative-intent surgery. J Clin Oncol. 2017;35:4042–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2017, 2020.

  11. Dasgupta N, Funk MJ, Proescholdbell S, et al. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med. 2016;17:85–98.

    PubMed  Google Scholar 

  12. Afonso A, Oskar S, Tan KS, et al. Is enhanced recovery the new standard of care in microsurgical breast reconstruction? Plast Reconstr Surg. 2017;139:1053–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Koehler RM, Okoroafor UC, Cannada LK. A systematic review of opioid use after extremity trauma in orthopedic surgery. Injury. 2018;49:1003–7.

    Article  PubMed  Google Scholar 

  14. Offodile AC 2nd, Gu C, Boukovalas S, et al. Enhanced recovery after surgery (ERAS) pathways in breast reconstruction: systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2019;173:65–77.

    Article  PubMed  Google Scholar 

  15. Voineskos SH, Nelson JA, Klassen AF, Pusic AL. Measuring patient-reported outcomes: key metrics in reconstructive surgery. Annu Rev Med. 2018;69:467–79.

    Article  CAS  PubMed  Google Scholar 

  16. Voineskos SH, Klassen AF, Cano SJ, Pusic AL, Gibbons CJ. Giving meaning to differences in BREAST-Q scores: minimal important difference for breast reconstruction patients. Plast Reconstr Surg. 2019;145:11e–20e.

    Article  CAS  Google Scholar 

  17. Rojas KE, Manasseh DM, Flom PL, et al. A pilot study of a breast surgery enhanced recovery after surgery (ERAS) protocol to eliminate narcotic prescription at discharge. Breast Cancer Res Treat. 2018;171:621–6.

    Article  PubMed  Google Scholar 

  18. Temple-Oberle C, Shea-Budgell MA, Tan M, et al. Consensus review of optimal perioperative care in breast reconstruction: Enhanced Recovery after Surgery (ERAS) Society Recommendations. Plast Reconstr Surg. 2017;139:1056e-e1071.

    Article  CAS  PubMed  Google Scholar 

  19. Parikh RP, Sharma K, Guffey R, Myckatyn TM. Preoperative paravertebral block improves postoperative pain control and reduces hospital length of stay in patients undergoing autologous breast reconstruction after mastectomy for breast cancer. Ann Surg Oncol. 2016;23:4262–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Langelotz C, Spies C, Muller JM, Schwenk W. “Fast-track”-rehabilitation in surgery, a multimodal concept. Acta Chir Belg. 2005;105:555–9.

    Article  CAS  PubMed  Google Scholar 

  21. Kehlet H, Dahl JB. Anaesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–8.

    Article  PubMed  Google Scholar 

  22. Fecho K, Miller NR, Merritt SA, et al. Acute and persistent postoperative pain after breast surgery. Pain Med. 2009;10:708–15.

    Article  PubMed  Google Scholar 

  23. Astanehe A, Temple-Oberle C, Nielsen M, et al. An enhanced recovery after surgery pathway for microvascular breast reconstruction is safe and effective. Plast Reconstr Surg Glob Open. 2018;6:e1634.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Batdorf NJ, Lemaine V, Lovely JK, et al. Enhanced recovery after surgery in microvascular breast reconstruction. J Plast Reconstr Aesthet Surg. 2015;68:395–402.

    Article  PubMed  Google Scholar 

  25. Bonde C, Khorasani H, Eriksen K, et al. Introducing the fast track surgery principles can reduce length of stay after autologous breast reconstruction using free flaps: a case control study. J Plast Surg Hand Surg. 2015;49:367–71.

    Article  PubMed  Google Scholar 

  26. Tokita H, Polanco T, Shamsunder M, et al. Non-narcotic perioperative pain management in prosthetic breast reconstruction during an opioid crisis: a systematic review of paravertebral blocks. Plast Reconstr Surg Glob Open. 2019;7:e2299.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Zhong T, Ojha M, Bagher S, et al. Transversus abdominis plane block reduces morphine consumption in the early postoperative period following microsurgical abdominal tissue breast reconstruction: a double-blind, placebo-controlled, randomized trial. Plast Reconstr Surg. 2014;134:870–8.

    Article  CAS  PubMed  Google Scholar 

  28. Beverly A, Kaye AD, Ljungqvist O, Urman RD. Essential elements of multimodal analgesia in enhanced recovery after surgery (ERAS) guidelines. Anesthesiol Clin. 2017;35:e115–43.

    Article  PubMed  Google Scholar 

  29. Salibian AA, Frey JD, Thanik VD, Karp NS, Choi M. Transversus abdominis plane blocks in microsurgical breast reconstruction: analysis of pain, narcotic consumption, length of stay, and cost. Plast Reconstr Surg. 2018;142:252e-e263.

    Article  CAS  PubMed  Google Scholar 

  30. Practice guidelines for acute pain management in the perioperative setting: an updated report by the American Society of Anesthesiologists Task Force on Acute Pain Management. Anesthesiology 2012: 116: 248–73.

  31. Walker NJ, Jones VM, Kratky L, Chen H, Runyan CM. Hematoma risks of nonsteroidal anti-inflammatory drugs used in plastic surgery procedures: a systematic review and meta-analysis. Ann Plast Surg. 2019;82:S437–45.

    Article  CAS  PubMed  Google Scholar 

  32. Stephens DM, Richards BG, Schleicher WF, Zins JE, Langstein HN. Is ketorolac safe to use in plastic surgery? A critical review. Aesthet Surg J. 2015;35:462–6.

    Article  PubMed  Google Scholar 

  33. Gobble RM, Hoang HL, Kachniarz B, Orgill DP. Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2014;133:741–55.

    Article  CAS  PubMed  Google Scholar 

  34. Klifto KM, Major MR, Leto Barone AA, et al. Perioperative systemic nonsteroidal anti‐inflammatory drugs (NSAIDs) in women undergoing breast surgery. Cochrane Datab Syst Rev 2019;(3):CD013290.

  35. Golden-Kreutz DM, Andersen BL. Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psychooncology. 2004;13:211–20.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Tsaras K, Papathanasiou IV, Mitsi D, et al. Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev. 2018;19:1661–9.

    PubMed  PubMed Central  Google Scholar 

  37. Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc. 2011;9:215–35.

    PubMed  Google Scholar 

  38. Roth RS, Lowery JC, Davis J, Wilkins EG. Psychological factors predict patient satisfaction with postmastectomy breast reconstruction. Plast Reconstr Surg 2007: 119: 2008–15; discussion 16–7.

  39. Ng CG, Mohamed S, Kaur K, et al. Perceived distress and its association with depression and anxiety in breast cancer patients. PLoS ONE. 2017;12:e0172975.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Hegel MT, Moore CP, Collins ED, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer. 2006;107:2924–31.

    Article  PubMed  Google Scholar 

  41. Marcusa DP, Mann RA, Cron DC, et al. Prescription opioid use among opioid-naive women undergoing immediate breast reconstruction. Plast Reconstr Surg. 2017;140:1081–90.

    Article  CAS  PubMed  Google Scholar 

  42. Waljee JF, Li L, Brummett CM, Englesbe MJ. Iatrogenic opioid dependence in the United States: are surgeons the gatekeepers? Ann Surg. 2017;265:728–30.

    Article  PubMed  Google Scholar 

  43. Nelson JA, Allen RJ Jr, Polanco T, et al. Long-term patient-reported outcomes following postmastectomy breast reconstruction: an 8-year examination of 3268 patients. Ann Surg. 2019;270:473–83.

    Article  PubMed  Google Scholar 

  44. Wilkins EG, Hamill JB, Kim HM, et al. Complications in postmastectomy breast reconstruction: one-year outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) study. Ann Surg. 2018;267:164–70.

    Article  PubMed  Google Scholar 

  45. Fischer JP, Nelson JA, Sieber B, et al. Free tissue transfer in the obese patient: an outcome and cost analysis in 1258 consecutive abdominally based reconstructions. Plast Reconstr Surg. 2013;131:681e-e692.

    Article  CAS  PubMed  Google Scholar 

  46. Fischer JP, Nelson JA, Kovach SJ, et al. Impact of obesity on outcomes in breast reconstruction: analysis of 15,937 patients from the ACS-NSQIP datasets. J Am Coll Surg. 2013;217:656–64.

    Article  PubMed  Google Scholar 

  47. Hitt HC, McMillen RC, Thornton-Neaves T, Koch K, Cosby AG. Comorbidity of obesity and pain in a general population: results from the Southern Pain Prevalence Study. J Pain. 2007;8:430–6.

    Article  PubMed  Google Scholar 

  48. Lloret Linares C, Decleves X, Oppert JM, et al. Pharmacology of morphine in obese patients: clinical implications. Clin Pharmacokinet. 2009;48:635–51.

    Article  PubMed  Google Scholar 

  49. Yanev N, Vlaskovska M. Pain in obesity is not obesity and pain. J of IMAB. 2016;22:1072–4.

    Article  Google Scholar 

  50. Karlsson HK, Tuominen L, Tuulari JJ, et al. Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. J Neurosci. 2015;35:3959–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis. 2004;23:39–53.

    Article  PubMed  Google Scholar 

  52. Rendon JL, Hodson T, Skoracki RJ, Humeidan M, Chao AH. Enhanced recovery after surgery protocols decrease outpatient opioid use in patients undergoing abdominally based microsurgical breast reconstruction. Plast Reconstr Surg. 2020;145:645–51.

    Article  CAS  PubMed  Google Scholar 

  53. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080.

    Article  PubMed  PubMed Central  Google Scholar 

  54. MacCallum RC, Zhang S, Preacher KJ, Rucker DD. On the practice of dichotomization of quantitative variables. Psychol Methods. 2002;7:19–40.

    Article  PubMed  Google Scholar 

  55. Kemp J, Despres O, Dufour A. Unreliability of the visual analog scale in experimental pain assessment: a sensitivity and evoked potentials study. Pain Phys. 2012;15:E693–9.

    Article  Google Scholar 

Download references

Funding

Research reported in this publication was supported in part by a National Institutes of Health (NIH) Cancer Center Support Grant P30CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jonas A. Nelson MD, MPH or Joseph H. Dayan MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nelson, J.A., Polanco, T.O., Shamsunder, M.G. et al. Perioperative Inpatient Opioid Consumption Following Autologous Free-Flap Breast Reconstruction Patients: An Examination of Risk and Patient-Reported Outcomes. Ann Surg Oncol 28, 7823–7833 (2021). https://doi.org/10.1245/s10434-021-10023-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-10023-z

Navigation